[New serological markers as a monitoring indicator for clinical cure of chronic hepatitis B]

Zhonghua Gan Zang Bing Za Zhi. 2018 Aug 20;26(8):565-567. doi: 10.3760/cma.j.issn.1007-3418.2018.08.002.
[Article in Chinese]

Abstract

The elimination of hepatitis B virus is not straightforward in chronic hepatitis B patients. A prolonged treatment and chance of recurrence after stopping the drug is a matter of concern for majority of specialists and patients. The traditional monitoring indicators and new serological markers for strengthening the determination of standard antiviral treatment of hepatitis B virus (HBV) has an important meaning towards clinical treatment and treatment protocol guiding regulations.

慢性乙型肝炎患者乙型肝炎病毒不容易被清除,用药疗程长,并且停药后容易复发。因此,慢性乙型肝炎抗病毒治疗何时停药备受广大专科医生及患者关注。加强抗乙型肝炎病毒治疗停药标准判定的传统监测指标和新的血清学标志物探讨,对于指导临床治疗以及治疗方案的调整具有重要意义。.

Keywords: Cure; Hepatitis B, chronic; Monitor; Serological markers.

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Biomarkers / blood
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / isolation & purification
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Recurrence

Substances

  • Antiviral Agents
  • Biomarkers
  • DNA, Viral
  • Hepatitis B Surface Antigens